https://tolleyhta.com/news2/2024-10-04T14:22:41+00:00https://tolleyhta.com/news3-2/2024-10-04T14:22:51+00:00https://tolleyhta.com/news3/2025-08-14T09:26:29+00:00https://tolleyhta.com/nice-home/2024-09-22T13:50:50+00:00https://tolleyhta.com/nice-home2/2024-09-20T17:05:14+00:00https://tolleyhta.com/nice-home2-copy/2024-10-28T22:19:44+00:00https://tolleyhta.com/case-health-economic/2024-11-01T12:06:10+00:00https://tolleyhta.com/nice-home-dummy/2024-11-04T15:28:18+00:00https://tolleyhta.com/case-health-technology/2024-11-01T13:32:26+00:00https://tolleyhta.com/health-technology-appraisal-of-gene-and-cell-therapies-for-rare-diseases/2024-11-01T17:33:01+00:00https://tolleyhta.com/elementor-2219/2024-11-01T17:27:49+00:00https://tolleyhta.com/disappointing-news-for-sickle-cell-disease-community-as-oxbryta-voxelotor-is-withdrawn-from-global-markets/2024-11-01T17:24:04+00:00https://tolleyhta.com/peak-district-ultra-challenge/2025-08-14T09:26:04+00:00https://tolleyhta.com/tolley-summer-teambuilding-event/2025-08-14T09:25:41+00:00https://tolleyhta.com/nice-recommend-the-first-therapy-to-treat-epidermolysis-bullosa/2024-11-04T15:29:01+00:00https://tolleyhta.com/publication-of-the-slr-and-nma-for-a-non-statin-lipid-lowering-therapy-for-patients-with-hypercholesterolaemia-following-successful-reimbursement-through-nice/2024-11-01T11:56:30+00:00https://tolleyhta.com/clare-proudfoot-raju-gautam-joaquim-cristino-rumjhum-agrawal-lalit-thakur-keith-tolley-model-parameters-influencing-the-cost-effectiveness-of-sacubitril-valsartan-in-heart-failure-evidence/2024-11-01T18:16:14+00:00https://tolleyhta.com/stainer-l-ryder-s-carr-e-collins-c-arora-m-tolley-k-a-structured-expert-elicitation-exercise-conducted-with-uk-clinicians-to-inform-and-validate-inputs-for-a-cost-effectiveness-analysis-of-fil/2024-11-01T18:17:00+00:00https://tolleyhta.com/worsley-c-bianco-m-noble-longster-j-prentice-e-prowse-a-cooper-c-strickson-a-a-systematic-review-of-clinical-efficacy-and-safety-data-in-penta-refractory-multiple-myeloma-findings-indicate-the/2024-11-01T18:15:43+00:00https://tolleyhta.com/keith-tolley-joanne-noble-longster-sam-mettam-rachel-hibbs-matthew-cawson-luke-stainer-tom-snell-ari-manuel-exploring-the-impact-of-excessive-daytime-sleepiness-caused-by-obstructive-sleep-apn/2024-11-01T18:15:15+00:00https://tolleyhta.com/keith-tolley-what-are-health-utilities-hayward-medical-publishing-2009/2024-11-01T18:14:50+00:00https://tolleyhta.com/stephen-kay-amanda-strickson-jorge-puelles-ross-selby-eugene-benson-keith-tolley-comparative-effectiveness-of-adding-alogliptin-to-metformin-plus-sulfonylurea-with-other-dpp-4-inhibitors-in/2024-11-01T18:14:23+00:00https://tolleyhta.com/challenges-and-opportunities-in-rare-disease-modelling/2026-03-31T14:52:30+00:00https://tolleyhta.com/one-and-done-hta-success/2024-11-07T10:21:15+00:00https://tolleyhta.com/a-new-process-model-for-study-identification-in-systematicreview-separating-studies-from-reports/2024-11-28T12:39:00+00:00https://tolleyhta.com/the-2023-eb-insights-study-the-impact-of-epidermolysis-bullosa-on-the-health-related-quality-of-life-of-patients-and-their-carers/2024-11-28T12:26:44+00:00https://tolleyhta.com/challenges-in-identifying-information-to-build-economic-evaluations-in-hereditary-angioedema/2024-11-28T12:29:35+00:00https://tolleyhta.com/whats-my-age-again-exploring-the-importance-of-patient-age-assumptions-in-calculating-severity-modifiers/2024-11-28T12:30:29+00:00https://tolleyhta.com/slrs-could-benefit-from-a-new-approach-to-study-identification-a-case-study/2024-11-28T12:31:14+00:00https://tolleyhta.com/health-technology-appraisals-of-gene-therapies-appraised-through-nice-highly-specialised-technology-route/2024-11-28T12:32:16+00:00https://tolleyhta.com/cost%e2%80%91effectiveness-of-tirzepatide-versus-liraglutideboth-adjunct-to-diet-and-exercise-for-patientswith-obesity-or-overweight-a-uk-perspective/2025-08-14T09:35:21+00:00https://tolleyhta.com/a-new-process-model-of-study-identification-specific-tothe-identification-of-randomised-studies-for-systematicreviews-of-medical-interventions/2025-08-14T09:36:06+00:00https://tolleyhta.com/tolley-2025-summer-team-building-event/2025-08-14T10:57:58+00:00https://tolleyhta.com/2025-tolley-team-fundraising-for-duchenne-uk/2025-08-14T11:50:52+00:00https://tolleyhta.com/steroid-burden-in-dmd-1/2025-12-09T12:10:40+00:00https://tolleyhta.com/a-systematic-approach-to-understanding-challenges-in-the-health-technology-assessment-of-rare-diseases/2025-11-11T10:05:55+00:00https://tolleyhta.com/the-2023-eb-insights-study-the-impact-of-epidermolysis-bullosa-on-carer-health-related-quality-of-life-poster-pcr226-presented-at-ispor-europe-2025-10-12-november-2025-glasgow-uk/2025-11-12T09:48:05+00:00https://tolleyhta.com/debra-study/2025-12-10T10:10:31+00:00https://tolleyhta.com/cost-effectiveness-of-once-weekly-rezafungin-for-the-treatment-of-invasive-candidiasis-in-the-united-kingdom/2026-02-17T12:00:50+00:00https://tolleyhta.com/setting-the-standard-with-the-jca-lessons-from-the-first-wave-of-eu-joint-clinical-assessments/2026-08-05T15:34:15+00:00